Podcast Journal Club

Erythrocytosis Risk in Trans Men

June 17, 2021


Join host Dr. Chase Hendrickson, Vanderbilt University Medical Center, for the June edition of Endocrine Feedback Loop. This episode, released June 17, 2021, features Dr. Anna Goldman, Associate Program Director at Brigham and Women’s Hospital, and Dr. Vin Tangpricha, Program Director at Emory University School of Medicine, expert in the endocrine care of persons with gender identity disorders, and a member of the Endocrine Society Transgender Research & Medicine Special Interest Group (SIG). If you’re interested in learning more about the Transgender Research & Medicine SIG and their upcoming webinars, visit their page here!

This month’s EFL discussion will focus on an article from the June 2021 edition of The Journal of Clinical Endocrinology & Metabolism: “Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years. ”

Meet the Speakers

Vin Tangpricha and Anna Goldman

Vin Tangpricha is a Professor of Medicine and program director for the fellowship program at Emory University School of Medicine in Atlanta, Georgia. Dr. Tangpricha received his medical degree from Tufts University School of Medicine and completed his internal medicine residency and endocrinology fellowship at Boston University Medical Center. He completed his Ph.D. degree in molecular medicine on the topic of vitamin D at Boston University School of Medicine. He serves on the Endocrine Society guidelines committee for the hormone treatment of gender-non-conforming and gender incongruent patients, which has published two international guidelines on transgender patients (2009 and revised in 2017). He served on the World Professional Association for Transgender Health guidelines for the Standards of Care (SOC) for Transgender people in 2011 and currently serves on the revision committee for an updated guideline, SOC8. He is the immediate past-president of the World Professional Association for Transgender Health. He has received funding from the Cystic Fibrosis Foundation and NIH. He has published over 200 peer reviewed manuscripts on transgender medicine, vitamin D and cystic fibrosis. Dr. Tangpricha is also an active member of the Endocrine Society’s Transgender Research & Medicine Special Interest Group (SIG), which supports research in transgender medicine and hosts regular webinars.

Anna Goldman, MD, received her medical degree from the Perelman School of Medicine at the University of Pennsylvania. She trained in internal medicine at the Icahn School of Medicine at Mount Sinai, where she also served as chief resident. She did her fellowship training in endocrinology at Brigham and Women’s hospital, during which she conducted research in andrology. Dr. Goldman is currently the associate program director for the endocrinology fellowship training program at BWH. Her career focus is on patient care in the areas of andrology, transgender care, diabetes, and medical education.


Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.